Jeffrey Silber

Chief Tech/Sci/R&D Officer at IRONWOOD PHARMACEUTICALS, INC.

Net worth: 579 662 $ as of 30/07/2026

Health Technology

Consumer Services

Profile

Jeffrey Silber currently works at Ironwood Pharmaceuticals, Inc., as Head-Research & Drug Development from 2026.
Dr. Silber also formerly worked at Vedanta Biosciences, Inc., as Chief Medical Officer from 2020 to 2026.
Dr. Silber received his undergraduate degree from Harvard University and doctorate degree from Albert Einstein College of Medicine, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IRONWOOD PHARMACEUTICALS, INC. CLASS A 0.08%	19/07/2026	137,036 ( 0.08% )	579 662 $	30/07/2026

Jeffrey Silber active positions

Companies	Position	Start
IRONWOOD PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	19/07/2026

All active positions of Jeffrey Silber

Former positions of Jeffrey Silber

Companies	Position	End
Vedanta Biosciences, Inc. Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system	Chief Tech/Sci/R&D Officer	30/06/2026

See the detail of Jeffrey Silber's experience

Training of Jeffrey Silber

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Silber's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albert Einstein College of Medicine, Inc. Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vedanta Biosciences, Inc. Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system	Health Technology